SHC - Sotera Health Company
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$22.00
DETAILS
HIGH:
$24.00
LOW:
$18.00
MEDIAN:
$24.00
CONSENSUS:
$22.00
UPSIDE:
37.84%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 1,163.6 | 1,100.4 | 1,049.3 | 1,003.7 | 931.5 | 818.2 | 778.3 | 746.1 |
| Cost of Revenue | 518.1 | 498.1 | 472.1 | 446.7 | 412.8 | 374.6 | 382.9 | 388.9 |
| Gross Profit | 645.5 | 602.3 | 577.2 | 557.0 | 518.7 | 443.6 | 395.4 | 357.3 |
| Operating Expenses | ||||||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 252.8 | 242.6 | 236.7 | 245.7 | 198.2 | 178.5 | 147.5 | 133.4 |
| Other Expenses | 0 | 62.0 | 63.8 | 62.9 | 63.8 | 59.0 | 64.4 | 143.0 |
| Operating Expenses | 252.8 | 304.7 | 300.5 | 308.7 | 261.9 | 237.6 | 211.8 | 191.3 |
| Operating Income | ||||||||
| Operating Income | 392.8 | 297.6 | 276.7 | 248.3 | 256.7 | 206.0 | 183.6 | 80.8 |
| Interest Expense | 155.7 | 164.7 | 142.9 | 80.1 | 74.2 | 215.3 | 157.7 | 143.3 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||
| EBITDA | 303.2 | 442.2 | 406.8 | (17.4) | 400.8 | 320.0 | 303.5 | 314.4 |
| EBIT | 303.2 | 278.6 | 248.9 | (163.0) | 249.9 | 176.4 | 156.8 | 167.5 |
| Income Before Tax | 147.5 | 113.9 | 106.0 | (243.1) | 175.7 | (38.9) | (0.9) | 24.2 |
| Income Tax Expense | 69.6 | 69.5 | 54.7 | (9.5) | 58.6 | (1.4) | 19.5 | 30.1 |
| Net Income | 77.9 | 44.4 | 51.4 | (233.6) | 116.9 | (38.6) | (20.9) | (5.9) |
| Per Share Data | ||||||||
| EPS (Basic) | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 | -0.14 | -0.07 | -0.02 |
| EPS (Diluted) | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 | -0.14 | -0.07 | -0.02 |
| Shares Outstanding | 284.0 | 282.8 | 281.0 | 280.1 | 279.2 | 283.2 | 284.4 | 246.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 346.5 | 277.2 | 296.4 | 395.2 | 106.9 | 102.4 | 62.9 | 96.3 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 176.3 | 165.8 | 175.5 | 155.7 | 134.0 | 131.0 | 111.6 | 141.6 |
| Inventory | 54.4 | 49.2 | 48.3 | 37.1 | 54.3 | 34.1 | 37.4 | 37.6 |
| Other Current Assets | 36.3 | 16.6 | 20.9 | 16.6 | 11.2 | 10.7 | 10.8 | 12.2 |
| Total Current Assets | 613.4 | 526.0 | 557.2 | 645.0 | 346.0 | 315.0 | 252.4 | 312.9 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 1,164.0 | 1,064.4 | 971.0 | 801.0 | 690.7 | 655.8 | 582.0 | 586.4 |
| Goodwill | 1,103.2 | 1,081.1 | 1,111.2 | 1,101.8 | 1,120.3 | 1,115.9 | 1,035.9 | 1,023.3 |
| Intangible Assets | 288.2 | 317.7 | 416.3 | 491.3 | 598.8 | 643.4 | 696.0 | 766.1 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 9.4 | 13.5 | 0 | 0 |
| Other Non-Current Assets | 94.4 | 79.6 | 69.7 | 74.6 | 18.3 | 9.3 | 12.2 | 4.2 |
| Total Non-Current Assets | 2,649.8 | 2,545.6 | 2,573.2 | 2,472.7 | 2,443.5 | 2,446.3 | 2,328.3 | 2,395.7 |
| Total Assets | 3,263.2 | 3,071.6 | 3,130.4 | 3,117.7 | 2,789.5 | 2,761.3 | 2,580.7 | 2,708.6 |
| Current Liabilities | ||||||||
| Account Payables | 78.0 | 55.1 | 71.0 | 74.1 | 72.9 | 52.4 | 42.0 | 46.4 |
| Short-Term Debt | 14.0 | 14.8 | 4.8 | 197.1 | 0 | 0 | 16.3 | 15.3 |
| Deferred Revenue | 0 | 15.1 | 13.5 | 12.1 | 8.7 | 6.1 | 3.6 | 4.6 |
| Other Current Liabilities | 142.7 | 41.1 | 36.9 | 43.1 | 37.2 | 38.8 | 37.3 | 50.6 |
| Total Current Liabilities | 249.6 | 191.0 | 230.7 | 791.6 | 161.2 | 140.6 | 124.0 | 143.4 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 2,126.7 | 2,208.1 | 2,223.7 | 1,747.1 | 1,743.5 | 1,824.8 | 2,800.9 | 2,189.6 |
| Deferred Tax Liabilities | 71.1 | 69.5 | 64.5 | 68.0 | 134.5 | 121.8 | 137.2 | 171.5 |
| Other Non-Current Liabilities | 69.0 | 61.6 | 65.3 | 63.3 | 69.6 | 124.4 | 108.5 | 106.2 |
| Total Non-Current Liabilities | 2,407.6 | 2,475.7 | 2,456.0 | 1,975.9 | 2,042.2 | 2,166.1 | 3,097.8 | 2,519.7 |
| Total Liabilities | 2,657.2 | 2,666.7 | 2,686.7 | 2,767.5 | 2,203.4 | 2,306.7 | 3,221.8 | 2,663.1 |
| Stockholders' Equity | ||||||||
| Common Stock | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | 2.3 | 2.3 |
| Retained Earnings | (532.1) | (610.0) | (654.4) | (705.8) | (472.2) | (589.1) | (550.5) | (10.4) |
| Accumulated Other Comprehensive Income | (109.8) | (208.3) | (92.7) | (106.7) | (83.6) | (93.8) | (94.4) | (110.0) |
| Total Stockholders' Equity | 606.0 | 404.9 | 443.7 | 350.2 | 586.1 | 452.3 | (642.6) | 44.4 |
| Total Liabilities & Equity | 3,263.2 | 3,071.6 | 3,130.4 | 3,117.7 | 2,789.5 | 2,761.3 | 2,580.7 | 2,708.6 |
| Debt Metrics | ||||||||
| Total Debt | 2,273.7 | 2,350.6 | 2,327.1 | 2,032.0 | 1,827.9 | 1,909.2 | 2,848.4 | 2,237.8 |
| Net Debt | 1,927.2 | 2,073.4 | 2,030.6 | 1,636.8 | 1,721.0 | 1,806.8 | 2,785.5 | 2,141.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | 77.9 | 44.4 | 51.4 | (233.6) | 117.1 | (37.5) | (20.4) | (5.9) |
| Depreciation & Amortization | 0 | 163.6 | 160.3 | 145.6 | 150.9 | 143.6 | 146.7 | 146.8 |
| Stock-Based Compensation | 0 | 36.8 | 32.2 | 21.2 | 13.9 | 11.0 | 6.9 | 6.9 |
| Change in Working Capital | 28.0 | (42.6) | (403.3) | 409.2 | (12.6) | (11.8) | (8.4) | 4.0 |
| Other Non-Cash Items | 181.2 | 12.6 | 8.2 | 9.5 | 16.0 | 38.7 | 43.2 | 13.0 |
| Operating Cash Flow | 287.2 | 224.2 | (147.7) | 278.0 | 281.5 | 120.6 | 149.0 | 119.6 |
| Investing Activities | ||||||||
| Capital Expenditure | (138.0) | (179.1) | (215.0) | (182.4) | (102.2) | (53.5) | (57.3) | (72.6) |
| Acquisitions | 0 | 0 | 0 | 0.5 | (57.0) | (105.2) | 0 | 162.8 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 2.9 | 0.1 | 0.1 | 0.0 | (0.7) | 0 | 0 | 6.4 |
| Investing Cash Flow | (135.1) | (179.0) | (214.9) | (181.9) | (159.8) | (158.7) | (57.3) | 96.6 |
| Financing Activities | ||||||||
| Net Debt Issuance | (86.1) | (11.8) | 297.5 | 200 | (100) | (1,027.3) | 583.5 | (14.6) |
| Stock Repurchased | 0 | (4.4) | (4.1) | (0.4) | (1.4) | (34) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | (691.2) | (175.8) |
| Other Financing Activities | (14.4) | (34.4) | (27.5) | (1.8) | (15.9) | (21.2) | (18.4) | (1.4) |
| Financing Cash Flow | (100.5) | (50.6) | 266.0 | 197.8 | (117.3) | 73.4 | (126.0) | (191.9) |
| Cash Position | ||||||||
| Net Change in Cash | 67.6 | (22.8) | (94.6) | 289.4 | 4.5 | 39.4 | (33.8) | 20.7 |
| Cash at Beginning | 278.9 | 301.7 | 396.3 | 106.9 | 102.5 | 63.0 | 96.8 | 76.1 |
| Cash at End | 346.5 | 278.9 | 301.7 | 396.3 | 106.9 | 102.5 | 63.0 | 96.8 |
| Free Cash Flow | 149.2 | 45.1 | (362.7) | 95.6 | 179.4 | 67.1 | 91.8 | 47.0 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,163.6 | 1,100.4 | 1,049.3 | 1,003.7 | 931.5 | 818.2 | 778.3 | 746.1 |
| Gross Profit | 645.5 | 602.3 | 577.2 | 557.0 | 518.7 | 443.6 | 395.4 | 357.3 |
| Operating Income | 392.8 | 297.6 | 276.7 | 248.3 | 256.7 | 206.0 | 183.6 | 80.8 |
| Net Income | 77.9 | 44.4 | 51.4 | (233.6) | 116.9 | (38.6) | (20.9) | (5.9) |
| EPS (Diluted) | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 | -0.14 | -0.07 | -0.02 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 346.5 | 277.2 | 296.4 | 395.2 | 106.9 | 102.4 | 62.9 | 96.3 |
| Total Assets | 3,263.2 | 3,071.6 | 3,130.4 | 3,117.7 | 2,789.5 | 2,761.3 | 2,580.7 | 2,708.6 |
| Total Debt | 2,273.7 | 2,350.6 | 2,327.1 | 2,032.0 | 1,827.9 | 1,909.2 | 2,848.4 | 2,237.8 |
| Stockholders' Equity | 606.0 | 404.9 | 443.7 | 350.2 | 586.1 | 452.3 | (642.6) | 44.4 |
| Cash Flow | ||||||||
| Operating Cash Flow | 287.2 | 224.2 | (147.7) | 278.0 | 281.5 | 120.6 | 149.0 | 119.6 |
| Capital Expenditure | (138.0) | (179.1) | (215.0) | (182.4) | (102.2) | (53.5) | (57.3) | (72.6) |
| Free Cash Flow | 149.2 | 45.1 | (362.7) | 95.6 | 179.4 | 67.1 | 91.8 | 47.0 |